Oral versions of dual agonists are in development
Lancet Diabetes Endocrinol 6(8):605617
Limit: weight regain is faster upon drug discontinuation than after surgery, and cumulative chronic treatment cost may equal or exceed surgery at 5-7 years
$143.00 High-Stability Polypeptide for Laboratory Evaluation Technical Overview Retatrutide is a synthetic peptide engineered to interact with multiple metabolic receptor systems including GLP-1, GIP, and glucagon receptors
The use of GLP-1 receptor agonists not only assists in achieving aesthetic goals but also contributes to metabolic health improvements, such as better blood glucose control and reduced cardiovascular risk factors
Brian Brian Cruz 5 out of 5 stars I have been a patient since 2018, visiting most all of their clinics, first starting at the Dallas Location, and now making my Home Clinic, at the Frisco Location